These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
245 related articles for article (PubMed ID: 2299764)
1. Failure of cephalosporins to prevent Staphylococcus aureus surgical wound infections. Kernodle DS; Classen DC; Burke JP; Kaiser AB JAMA; 1990 Feb; 263(7):961-6. PubMed ID: 2299764 [TBL] [Abstract][Full Text] [Related]
2. Which cephalosporin for wound prophylaxis? An experimental comparison of three drugs. Scher KS; Jones CW Surgery; 1985 Jul; 98(1):30-4. PubMed ID: 3892746 [TBL] [Abstract][Full Text] [Related]
3. Cefamandole versus cefazolin in vascular surgical wound infection prophylaxis: cost-effectiveness and risk factors. Edwards WH; Kaiser AB; Tapper S; Edwards WH; Martin RS; Mulherin JL; Jenkins JM; Roach AC J Vasc Surg; 1993 Sep; 18(3):470-5; discussion 475-6. PubMed ID: 8377241 [TBL] [Abstract][Full Text] [Related]
4. Comparative study of cefazolin, cefamandole, and vancomycin for surgical prophylaxis in cardiac and vascular operations. A double-blind randomized trial. Maki DG; Bohn MJ; Stolz SM; Kroncke GM; Acher CW; Myerowitz PD J Thorac Cardiovasc Surg; 1992 Nov; 104(5):1423-34. PubMed ID: 1434726 [TBL] [Abstract][Full Text] [Related]
5. Correlation of in-vitro parameters of antimicrobial activity with prophylactic efficacy in an intradermal model of Staphylococcus aureus infection. Warren MD; Kernodle DS; Kaiser AB J Antimicrob Chemother; 1991 Nov; 28(5):731-40. PubMed ID: 1778876 [TBL] [Abstract][Full Text] [Related]
6. Comparison of cefamandole and cefazolin during cardiopulmonary bypass. Bryan CS; Smith CW; Sutton JP; Allen WB; Blanding R; Gangemi JD J Thorac Cardiovasc Surg; 1983 Aug; 86(2):222-5. PubMed ID: 6348425 [TBL] [Abstract][Full Text] [Related]
7. Surgical prophylaxis: how far have we really come? Kernodle DS Pharmacotherapy; 1988; 8(6 Pt 2):11S-13S. PubMed ID: 3075742 [TBL] [Abstract][Full Text] [Related]
8. Efficacy of cefazolin, cefamandole, and gentamicin as prophylactic agents in cardiac surgery. Results of a prospective, randomized, double-blind trial in 1030 patients. Kaiser AB; Petracek MR; Lea JW; Kernodle DS; Roach AC; Alford WC; Burrus GR; Glassford DM; Thomas CS; Stoney WS Ann Surg; 1987 Dec; 206(6):791-7. PubMed ID: 3689015 [TBL] [Abstract][Full Text] [Related]
9. Beta-lactamase production diminishes the prophylactic efficacy of ampicillin and cefazolin in a guinea pig model of Staphylococcus aureus wound infection. Kernodle DS; Voladri RK; Kaiser AB J Infect Dis; 1998 Mar; 177(3):701-6. PubMed ID: 9498450 [TBL] [Abstract][Full Text] [Related]
10. Antibiotic prophylaxis in open-heart surgery: a comparison of cefamandole, cefuroxime, and cefazolin. Gentry LO; Zeluff BJ; Cooley DA Ann Thorac Surg; 1988 Aug; 46(2):167-71. PubMed ID: 3401076 [TBL] [Abstract][Full Text] [Related]
11. [Susceptibility to cefazolin, cefamandole and ceftazidime in Staphylococcus strains]. Wiktorowicz-Belzyt E; Wojak I; Janicka G Med Dosw Mikrobiol; 1997; 49(1-2):35-43. PubMed ID: 9411070 [TBL] [Abstract][Full Text] [Related]
12. Association of borderline oxacillin-susceptible strains of Staphylococcus aureus with surgical wound infections. Kernodle DS; Classen DC; Stratton CW; Kaiser AB J Clin Microbiol; 1998 Jan; 36(1):219-22. PubMed ID: 9431951 [TBL] [Abstract][Full Text] [Related]
13. Use of cefazolin microspheres to treat localized methicillin-resistant Staphylococcus aureus infections in rats. Fallon MT; Shafer W; Jacob E J Surg Res; 1999 Sep; 86(1):97-102. PubMed ID: 10452874 [TBL] [Abstract][Full Text] [Related]
14. Clinical implications of cefazolin inoculum effect and β-lactamase type on methicillin-susceptible Staphylococcus aureus bacteremia. Lee S; Kwon KT; Kim HI; Chang HH; Lee JM; Choe PG; Park WB; Kim NJ; Oh MD; Song DY; Kim SW Microb Drug Resist; 2014 Dec; 20(6):568-74. PubMed ID: 25000230 [TBL] [Abstract][Full Text] [Related]
15. Vancomycin versus cefazolin prophylaxis for cerebrospinal shunt placement in a hospital with a high prevalence of meticillin-resistant Staphylococcus aureus. Tacconelli E; Cataldo MA; Albanese A; Tumbarello M; Arduini E; Spanu T; Fadda G; Anile C; Maira G; Federico G; Cauda R J Hosp Infect; 2008 Aug; 69(4):337-44. PubMed ID: 18602187 [TBL] [Abstract][Full Text] [Related]
16. Antibiotic prophylaxis in open-heart surgery patients: comparison of cefamandole and cefuroxime. Peterson CD; Lake KD; Arom KV; Love KR Drug Intell Clin Pharm; 1987 Sep; 21(9):728-32. PubMed ID: 3498617 [TBL] [Abstract][Full Text] [Related]
17. Cefuroxime versus cefazolin as prophylaxis in vascular surgery. Edwards WH; Kaiser AB; Kernodle DS; Appleby TC; Edwards WH; Martin RS; Mulherin JL; Wood CA J Vasc Surg; 1992 Jan; 15(1):35-41; discussion 41-2. PubMed ID: 1728688 [TBL] [Abstract][Full Text] [Related]
18. Comparison of cefazolin, cefamandole, vancomycin, and LY146032 for prophylaxis of experimental Staphylococcus epidermidis endocarditis. Wheat LJ; Smith JW; Reynolds J; Bemis AT; Treger T; Norton JA Antimicrob Agents Chemother; 1988 Jan; 32(1):63-7. PubMed ID: 2831815 [TBL] [Abstract][Full Text] [Related]
19. Association of a bundled intervention with surgical site infections among patients undergoing cardiac, hip, or knee surgery. Schweizer ML; Chiang HY; Septimus E; Moody J; Braun B; Hafner J; Ward MA; Hickok J; Perencevich EN; Diekema DJ; Richards CL; Cavanaugh JE; Perlin JB; Herwaldt LA JAMA; 2015 Jun; 313(21):2162-71. PubMed ID: 26034956 [TBL] [Abstract][Full Text] [Related]